Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
natural killer cell | 4 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of NMUR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 94% | 149.29 | 84 / 89 | 65% | 2.63 | 583 / 901 |
pancreas | 99% | 310.50 | 326 / 328 | 57% | 1.17 | 102 / 178 |
prostate | 94% | 236.15 | 231 / 245 | 54% | 1.28 | 273 / 502 |
intestine | 85% | 176.82 | 825 / 966 | 46% | 1.03 | 245 / 527 |
lung | 99% | 410.52 | 571 / 578 | 32% | 0.74 | 365 / 1155 |
stomach | 72% | 101.23 | 257 / 359 | 56% | 1.54 | 159 / 286 |
adrenal gland | 92% | 137.98 | 237 / 258 | 26% | 0.47 | 60 / 230 |
bladder | 86% | 220.38 | 18 / 21 | 24% | 0.51 | 120 / 504 |
thymus | 88% | 147.58 | 577 / 653 | 20% | 0.35 | 118 / 605 |
breast | 89% | 256.53 | 409 / 459 | 17% | 0.39 | 192 / 1118 |
esophagus | 82% | 293.72 | 1181 / 1445 | 19% | 0.30 | 34 / 183 |
spleen | 100% | 599.23 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 423.33 | 1189 / 1204 | 0% | 0 | 0 / 0 |
uterus | 79% | 114.26 | 134 / 170 | 17% | 0.68 | 76 / 459 |
peripheral blood | 77% | 468.30 | 717 / 929 | 0% | 0 | 0 / 0 |
liver | 64% | 61.09 | 144 / 226 | 12% | 0.28 | 48 / 406 |
eye | 0% | 0 | 0 / 0 | 73% | 2.64 | 58 / 80 |
blood vessel | 64% | 103.25 | 855 / 1335 | 0% | 0 | 0 / 0 |
skin | 25% | 23.92 | 459 / 1809 | 25% | 0.70 | 117 / 472 |
heart | 48% | 48.07 | 414 / 861 | 0% | 0 | 0 / 0 |
ovary | 19% | 31.20 | 34 / 180 | 20% | 0.45 | 88 / 430 |
brain | 17% | 24.57 | 436 / 2642 | 3% | 0.04 | 18 / 705 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.23 | 4 / 29 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.43 | 5 / 45 |
muscle | 3% | 2.39 | 24 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006939 | Biological process | smooth muscle contraction |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0006821 | Biological process | chloride transport |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0042924 | Molecular function | neuromedin U binding |
GO_0008188 | Molecular function | neuropeptide receptor activity |
GO_0001607 | Molecular function | neuromedin U receptor activity |
Gene name | NMUR1 |
Protein name | Neuromedin-U receptor 1 (NMU-R1) (G-protein coupled receptor 66) (G-protein coupled receptor FM-3) Alternative protein NMUR1 |
Synonyms | GPR66 |
Description | FUNCTION: Receptor for the neuromedin-U and neuromedin-S neuropeptides. . |
Accessions | Q9HB89 ENST00000305141.5 L8E9D8 |